MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 15, Pages 8653
Publisher
MDPI AG
Online
2022-08-04
DOI
10.3390/ijms23158653
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma
- (2022) Ru Wang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Acromegaly and Colorectal Neoplasm: An Update
- (2022) Leandro Kasuki et al. Frontiers in Endocrinology
- A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer
- (2021) Alireza Ahadi IMMUNOGENETICS
- An update on the role of miR-124 in the pathogenesis of human disorders
- (2021) Soudeh Ghafouri-Fard et al. BIOMEDICINE & PHARMACOTHERAPY
- Machine learning-based prediction model for treatment of acromegaly with first-generation somatostatin receptor ligands
- (2021) Luiz Eduardo Wildemberg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNA-mediated regulation of glucose and lipid metabolism
- (2021) Pamela Agbu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Analysis of periodontitis-associated miRNAs in gingival tissue, gingival crevicular fluid, saliva and blood plasma
- (2021) Adomas Rovas et al. ARCHIVES OF ORAL BIOLOGY
- Circulating plasma MicroRNA in patients with active acromegaly
- (2021) Alexander Lutsenko et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Future of Somatostatin Receptor Ligands in Acromegaly
- (2021) Monica R Gadelha et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
- (2021) Luiz Eduardo Wildemberg et al. Cancers
- miR-524-5p inhibits angiogenesis through targeting WNK1 in colon cancer cells
- (2020) Xiang Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- MiR-524-5p Suppresses Migration, Invasion, and EMT Progression in Breast Cancer Cells Through Targeting FSTL1
- (2020) Taobo Jin et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
- (2020) Ningni Jiang et al. MOLECULAR BIOLOGY REPORTS
- miR‑452‑5p and miR‑215‑5p expression levels in colorectal cancer tissues and their relationship with clinicopathological features
- (2020) Jingbo Yan et al. Oncology Letters
- Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
- (2020) Shihori Tanabe et al. Frontiers in Pharmacology
- Acromegaly
- (2020) Leandro Kasuki et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- miR ‐34a is upregulated in AIP ‐ mutated somatotropinomas and promotes octreotide resistance
- (2020) Eva‐Maria Bogner et al. INTERNATIONAL JOURNAL OF CANCER
- A Pituitary Society update to acromegaly management guidelines
- (2020) Maria Fleseriu et al. Pituitary
- miR-525-5p Modulates Proliferation and Epithelial–Mesenchymal Transition of Glioma by Targeting Stat-1
- (2020) Peng Xie et al. OncoTargets and Therapy
- MicroRNA-381—A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer
- (2020) Xue Zeng et al. Frontiers in Oncology
- Wnt pathway targeting reduces triple‐negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo
- (2019) Samira Mohammadi‐Yeganeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Biological Function and Clinical Significance of miR-886-5p in Multiple Myeloma
- (2019) Pu Xiang et al. ACTA HAEMATOLOGICA
- Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas
- (2019) Sida Zhao et al. International Journal of Endocrinology
- Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid
- (2019) Petros Takousis et al. Alzheimers & Dementia
- MiR-525-5p Repressed Metastasis and Anoikis Resistance in Cervical Cancer via Blocking UBE2C/ZEB1/2 Signal Axis
- (2019) Mei Chen et al. DIGESTIVE DISEASES AND SCIENCES
- Deciphering miRNAs’ Action through miRNA Editing
- (2019) Marta Correia de Sousa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metazoan MicroRNAs
- (2018) David P. Bartel CELL
- Extracellular Vesicles in Lung Disease
- (2018) Hiroshi Kubo CHEST
- MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly
- (2018) Leandro Kasuki et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- MicroRNAs and Target Genes in Pituitary Adenomas
- (2018) Yajuan Feng et al. HORMONE AND METABOLIC RESEARCH
- Risk category system to identify pituitary adenoma patients withAIPmutations
- (2018) Francisca Caimari et al. JOURNAL OF MEDICAL GENETICS
- Systemic complications of acromegaly and the impact of the current treatment landscape: an update
- (2018) Mônica R Gadelha et al. ENDOCRINE REVIEWS
- Post-transcriptional control of miRNA biogenesis
- (2018) Gracjan Michlewski et al. RNA
- Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical control
- (2017) Hormones-International Journal of Endocrinology and Metabolism
- AIP and the somatostatin system in pituitary tumours
- (2017) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Somatostatin receptor ligands in the treatment of acromegaly
- (2017) Monica R. Gadelha et al. Pituitary
- AIP mutations in Brazilian patients with sporadic pituitary adenomas: a single-center evaluation
- (2017) Paula Bruna Araujo et al. Endocrine Connections
- Pasireotide for the treatment of acromegaly
- (2016) Luiz Eduardo Wildemberg et al. EXPERT OPINION ON PHARMACOTHERAPY
- Degradation dynamics of microRNAs revealed by a novel pulse-chase approach
- (2016) Matteo J. Marzi et al. GENOME RESEARCH
- Re-evaluation of the roles ofDROSHA,Exportin 5, andDICERin microRNA biogenesis
- (2016) Young-Kook Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
- (2015) Donato Iacovazzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis
- (2015) Z. A. Efstathiadou et al. Pituitary
- Circulating miRNAs as biomarkers for endocrine disorders
- (2015) H. Butz et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185
- (2015) X. Fan et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
- (2015) Judit Dénes et al. PLoS One
- The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
- (2014) Eric Monsalves et al. ENDOCRINE-RELATED CANCER
- MicroRNAs: Suggested role in pituitary adenoma pathogenesis
- (2014) M. R. Gadelha et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial–mesenchymal transition (EMT) in SCC15 cells
- (2014) Enjiao Zhang et al. TUMOR BIOLOGY
- Pttg1 inhibits TGFβ signaling in breast cancer cells to promote their growth
- (2014) Guofeng Zhang et al. TUMOR BIOLOGY
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis
- (2013) Thomas Cuny et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genome-Wide Analysis of Human MicroRNA Stability
- (2013) Yang Li et al. Biomed Research International
- MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
- (2012) Giampaolo Trivellin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Putative Tumor Suppressor miR-524–5p Directly Targets Jagged-1 and Hes-1 in Glioma
- (2012) Lingchao Chen et al. CARCINOGENESIS
- Germline AIP Mutations in Apparently Sporadic Pituitary Adenomas: Prevalence in a Prospective Single-Center Cohort of 443 Patients
- (2012) Laure Cazabat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1
- (2012) Daniela D'Angelo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway
- (2012) T Palumbo et al. ONCOGENE
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
- (2011) Kasey C. Vickers et al. NATURE CELL BIOLOGY
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
- (2011) J. D. Arroyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential expression of microRNAs in GH-secreting pituitary adenomas
- (2010) Zhi-Gang Mao et al. Diagnostic Pathology
- MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells
- (2010) Jing-Hua Li et al. GYNECOLOGIC ONCOLOGY
- Guidelines for Acromegaly Management: An Update
- (2009) S. Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas
- (2009) Zhi Rong Qian et al. MODERN PATHOLOGY
- Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
- (2008) Charles H. Lawrie et al. BRITISH JOURNAL OF HAEMATOLOGY
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Detection and Characterization of Placental MicroRNAs in Maternal Plasma
- (2008) S. S.C. Chim et al. CLINICAL CHEMISTRY
- Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update
- (2008) F. Salehi et al. ENDOCRINE-RELATED CANCER
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNAs and Possible Role in Pituitary Adenoma
- (2008) Maria Zatelli et al. SEMINARS IN REPRODUCTIVE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started